The FDA approved a new drug to treat Alzheimer’s, but Medicare won’t always pay for it – a doctor explains what researchers know about Biogen’s Aduhelm
The FDA approved a new drug to treat Alzheimer’s, but Medicare won’t always pay for it – a doctor explains what researchers know about Biogen’s Aduhelm